Control charts diagnose endophthalmitis

Article

Control charts are an accurate way of measuring disparity in endophthalmitis following phacoemulsification, according to a study published online ahead of print by Eye.

Control charts are an accurate way of measuring disparity in endophthalmitis following phacoemulsification, according to a study published online ahead of print by Eye.

Patrick J. T. Chiam, MRCOphth of the Eye Department, Royal Dwent Hospital, Newport, UK and colleagues conducted a ten-year retrospective analysis of variety in post-cataract surgery endophthalmitis by applying the control chart method, using specified criteria to discern any deviations of the disease. During the study period (July 1 1997–June 30 2007), 21032 cataract surgeries were performed, with an endophthalmitis incidence of 0.16%.

The researchers found that, using control charts, it was possible reliably to detect endophthalmitis much earlier in the disease progression than symptom manifestation.

The team therefore concluded that the control chart method is a safe, reliable and sensitive way to determine postoperative endophthalmitis, particularly if there are any anomalies present.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.